SecureBio is a research non-profit that works to advance biotechnology safely and prevent catastrophic pandemics.

Joined January 2025
In our brief independent assessment, Gemini 4 Argon is the second-highest scoring model on SecureBio's Bio Capabilities Index: 169, behind only Claude Opus 5 (176). On BioTIER, Argon refuses 87.8% of hazardous prompts, up from 62.8% for Gemini 3.1 Pro. Read the full model note here: securebio.substack.com/p/gem… On our knowledge benchmarks, Argon is roughly tied for the top score on VCT-v2 (57.3% vs. 58.0% for GPT-6 Astra), second on MBCT (63.2%), and highest on HPCT (74.2%, though 29.1% of questions were refused). It ranks sixth on WCB. We welcome GDM's substantial safety report. We'd like more detail on how third-party evaluations were run, and more testing of long-horizon agentic capabilities and of uplift for well-resourced groups. Agentic benchmark results for Argon will follow on our dashboard.
1
7
374
A common argument for downplaying the threat of deliberate biological misuse is that “nature is the worst bioterrorist”. In our latest blog, we argue that nature is the baseline, not the ceiling. Optimization for harm could produce something worse than a natural pandemic. Read more: securebio.substack.com/p/nat…
5
296
Frontier AI now beats the best human virologists on biosecurity-relevant evals. Once an AI model bests every human expert we can test it against, a higher score stops telling us anything about real-world risk. Read our new blog post on how bio evals have to adapt: securebio.org/blog/evaluatin…
3
12
605
Untargeted wastewater metagenomic sequencing screens hundreds of pathogens at once, but that breadth costs coverage, making variant tracking more difficult. However, by pooling CASPER reads nationally, we can recover real lineage and genotype trends. Read more: securebio.org/blog/tracking-…
1
155
Model accuracy dropped only 1.0–7.1 points on VCT-v2, and the gap between strongest and weakest models held steady, so past VCT results remain largely valid. VCT-v2 also has more headroom before saturation: at least ~30 points vs. ~23 on the original VCT.
1
55
We found that 27% of the original VCT questions were shortcut-exploitable (answerable without the image or question text). In all, we edited 163 questions (50.6%) and removed 43 questions (including 25 non-discriminating ones) to produce the 279-question VCT-v2 benchmark.
1
1
66
Top model accuracy on the original VCT has risen ~12 points since April 2025 (o3: 42.0%; GPT-5.6 Sol: 53.9%). To ensure this benchmark continues to capture the full dynamic range of model capabilities, we audited all 322 questions for validity and shortcut-resistance.
1
1
111
We updated our flagship virology troubleshooting benchmark, the Virology Capabilities Test (VCT), to be more shortcut-resistant and to have a larger headroom. We confirmed that the majority of VCT questions are scientifically valid and that neither VCT nor VCT-v2 is saturated. (Read the full post at securebio.substack.com/p/int…)
1
1
5
392
We are continuing to refine our processes and methods for escalating hits on our biosurveillance and notification system, SecureBio Alerts. We cover several of these (and some other particularly interesting CASPER detections) in a recent blog post. securebio.org/blog/rare-viru…
1
1
61
Meanwhile, our nasal swab sampling program, Zephyr, achieved a new single-day collection record (401 swabs) on May 9. Real-time data from this work is available on our Zephyr Dashboard. data.securebio.org/zephyr/
1
1
45